The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
The Department of Energy (DOE) has relaunched the coal auction for the Semirara mine in Antique,
Converge ICT Solutions Inc. is facing challenges in acquiring and retaining low-income subscribers as rising inflation
Business name registrations with the Department of Trade and Industry (DTI) increased by 6.5 percent to
The Philippine Ports Authority (PPA) recorded a 15-percent increase in profit to P10.59 billion in the
Converge Information and Communications Technology Solutions Inc. reported a four percent increase in consolidated revenues to